Marine Drugs · 2014 · 40 citations · 20 references
Natural SciencesMedicinal ChemistryPharmacologyBiochemical PharmacologyCancer PharmacologyDrug DiscoveryMarine Bioactive CompoundsMarine Drug DiscoveryMarine Natural ProductsMarine PharmacologyPeptide Drug DiscoveryProstate CancerBioactive Compounds From Marine SpongesBioactive Marine MetabolitesBioactive Marine PeptidesMarine Sponge MetabolitesMarine-derived Anticancer CompoundsSecondary MetabolitesSponges As Drug SourcesSponges-derived Metabolites
Two consecutive prefractionated fractions of the Australian marine sponge extract, Pipestela candelabra, were identified to be selectively active on the human prostate cancer cells (PC3) compared to the human neonatal foreskin fibroblast non-cancer cells (NFF). Twelve secondary metabolites were isolated in which four compounds are new small peptides. Their structures were characterized by spectroscopic and chemical analysis. These compounds inhibited selectively the growth of prostate cancer cells with IC50 values in the picomolar to sub-micromolar range. Structure-activity relationship of these compounds is discussed.
20
Cytotoxic peptides from the marine sponge Cymbastela sp.
John E. Coleman, E. Dilip de Silva, Fangming Kong et al. · Tetrahedron · 1995 · 156 citations